TherapeuticsMD (TXMD) Enterprise Value (2016 - 2025)
TherapeuticsMD's Enterprise Value history spans 16 years, with the latest figure at -$7.5 million for Q4 2025.
- For Q4 2025, Enterprise Value fell 47.91% year-over-year to -$7.5 million; the TTM value through Dec 2025 reached -$7.5 million, down 47.91%, while the annual FY2025 figure was -$7.5 million, 47.91% down from the prior year.
- Enterprise Value reached -$7.5 million in Q4 2025 per TXMD's latest filing, down from -$7.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$4.3 million in Q4 2023 to a low of -$137.6 million in Q1 2021.
- Average Enterprise Value over 5 years is -$34.4 million, with a median of -$11.9 million recorded in 2023.
- Peak YoY movement for Enterprise Value: skyrocketed 92.86% in 2023, then tumbled 47.91% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$64.9 million in 2021, then increased by 6.69% to -$60.6 million in 2022, then surged by 92.86% to -$4.3 million in 2023, then dropped by 16.92% to -$5.1 million in 2024, then crashed by 47.91% to -$7.5 million in 2025.
- Per Business Quant, the three most recent readings for TXMD's Enterprise Value are -$7.5 million (Q4 2025), -$7.1 million (Q3 2025), and -$6.1 million (Q2 2025).